Genetically engineered mouse models (GEMMs) of lung cancer and immunohistochemistry of human lung cancer tissues have demonstrated that the TME of FGFR-mutant tumors is characterized by low T-cell infiltration and high PD-L1 expression in tumors and immune cells [23]. The gene discussed is CD274; the disease is lung carcinoma.